Lila Morgan

Black women in Canada and the United States face significantly higher breast cancer mortality rates and later-stage diagnoses than white women, despite being diagnosed at younger ages. Systemic barriers, including medical mistrust and a lack of culturally informed care, contribute to these disparities, leading health experts to call for personalized, earlier screening protocols. The Disparity … Read more

BANGKOK — Thai health authorities are investigating six private hospitals over suspected fraudulent birth registrations that may have enabled foreign-born children to obtain Thai nationality through falsely declared Thai fathers, according to the Public Health Ministry. The probe, part of a broader crackdown on a network allegedly exploiting Thai men as “fake fathers,” has flagged … Read more

A clinical study published in JCO Oncology Practice reveals that weekly electronic symptom check-ins significantly improve quality of life for patients with advanced cancer. The PRO-TECT trial, involving nearly 1,200 participants, demonstrates that these digital interventions effectively bridge communication gaps, particularly benefiting underserved groups and reducing emergency department visits. The PRO-TECT Trial: Methodology and Reach … Read more

Recent research has established a direct link between aberrant DNA methylation and the onset of aging-related phenotypes, providing significant evidence that these epigenetic changes are a causal factor in biological aging. By studying Heyn–Sproul–Jackson syndrome (HESJAS), researchers have demonstrated how poorly restrained DNA methylation leads to the transcriptional deregulation of key genes, resulting in stem … Read more

Blood Test Predicts Cognitive Decline a Decade Before Symptoms A blood test measuring the Alzheimer’s biomarker p-tau217 can predict a person’s risk of cognitive decline up to a decade before symptoms appear, according to data presented at the Alzheimer’s Association International Conference (AAIC) 2026. This prognostic tool could transform early detection and prevention efforts by … Read more

Global childhood vaccination rates improved slightly in 2025, with 90% of infants receiving at least one dose of the DTP vaccine. Despite this progress, 13.5 million children remain completely unvaccinated, as conflict and funding cuts threaten to reverse these fragile gains and trigger future health risks. 2025 Immunization Progress and the Zero-Dose Gap New estimates … Read more

A new study has found that regular coffee consumption, including both caffeinated and decaffeinated varieties, is associated with a lower likelihood of developing serious liver ailments. According to researchers at Cedars-Sinai, individuals who drink coffee on a daily basis show fewer cases of cirrhosis, liver cancer, and liver-related death compared to those who do not … Read more

Initiating prostate cancer screening before the age of 50, combined with maintaining lower baseline prostate-specific antigen (PSA) levels, is associated with a significantly reduced risk of being diagnosed with metastatic prostate cancer, according to a recent study of U.S. veterans. Among the cohort, 3,773 participants—or 3.7%—were diagnosed with metastatic prostate cancer at the time of … Read more

Researchers have identified a new digital platform, iACT4CARERS, that significantly reduces anxiety and depression in family members caring for people with dementia. The intervention, which combines online therapy sessions with minimal support from NHS workers, demonstrated sustained mental health improvements in a national trial led by the University of East Anglia. iACT4CARERS Trial Results and … Read more

A second U.S. citizen working in the Democratic Republic of Congo has been evacuated to Germany for treatment after testing positive for the rare Bundibugyo strain of Ebola. As of July 12, 2026, the outbreak has reported 1,926 cases and 702 deaths, prompting international concern over the virus’s rapid spread and lack of approved vaccines. … Read more

University of Houston chemist Tai-Yen Chen has received a $2.16 million National Institutes of Health grant to study how copper imbalances in neurons contribute to neurodegenerative diseases. This five-year funding follows his lab’s recent discovery of a dynamic copper-regulating protein, offering a new quantitative approach to understanding Alzheimer’s and other incurable disorders. Decoding Copper’s Role … Read more

CEL-SCI Corporation has announced the initiation of an FDA registration-enabling confirmatory study for leukocyte interleukin injection (Multikine) as a neoadjuvant treatment for newly diagnosed, previously untreated, resectable, locally advanced primary head and neck cancer. The study aims to validate findings from a previously completed Phase 3 trial and serves as a definitive step toward establishing … Read more